Last reviewed · How we verify
TNF kinoid
At a glance
| Generic name | TNF kinoid |
|---|---|
| Sponsor | Neovacs |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis (PHASE2)
- Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients (PHASE2)
- Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists (PHASE2)
- Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TNF kinoid CI brief — competitive landscape report
- TNF kinoid updates RSS · CI watch RSS
- Neovacs portfolio CI